Genetic associations between circulating metabolic biomarkers and lung cancer in East Asians and Europeans

[1]  Y. J. Kim,et al.  The contribution of common and rare genetic variants to variation in metabolic traits in 288,137 East Asians , 2022, Nature Communications.

[2]  Li Jin,et al.  Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases. , 2022, Metabolism: clinical and experimental.

[3]  V. Zuber,et al.  Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches , 2022, American journal of human genetics.

[4]  Christopher D. Brown,et al.  The power of genetic diversity in genome-wide association studies of lipids , 2021, Nature.

[5]  M. Rivas,et al.  A cross-population atlas of genetic associations for 220 human phenotypes , 2021, Nature Genetics.

[6]  Ravensara S. Travillian,et al.  Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2021, The Lancet. Respiratory medicine.

[7]  K. Kashfi,et al.  Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. , 2021, Biochemical pharmacology.

[8]  W. Liang,et al.  Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study. , 2021, Seminars in arthritis and rheumatism.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  Ross M. Fraser,et al.  Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability , 2020, Nature Communications.

[11]  E. Lerma,et al.  LDL, HDL and endocrine-related cancer: from pathogenic mechanisms to therapies. , 2020, Seminars in cancer biology.

[12]  Z. Shao,et al.  Mendelian randomization study of inflammatory bowel disease and bone mineral density , 2020, BMC Medicine.

[13]  S. Bojesen,et al.  Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals , 2020, Journal of Hematology & Oncology.

[14]  F. Hu,et al.  Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts. , 2020, Journal of the National Cancer Institute.

[15]  L. Kiemeney,et al.  Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization , 2020, International journal of cancer.

[16]  O. Hejlesen,et al.  Associations between smoking, glucose metabolism and lipid levels: A cross-sectional study. , 2020, Journal of diabetes and its complications.

[17]  S. Larsson,et al.  Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study , 2020, Diabetes.

[18]  J. Bowden,et al.  Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomization , 2020, bioRxiv.

[19]  T. Rohan,et al.  Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[20]  F. Tan,et al.  Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort study , 2019, International journal of cancer.

[21]  Jiayi Shen,et al.  Education and lung cancer: a Mendelian randomization study. , 2019, International journal of epidemiology.

[22]  S. Djurovic,et al.  Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence , 2019, Molecular Psychiatry.

[23]  Miaomei Yu,et al.  Dyslipidemia and non-small cell lung cancer risk in Chinese population: a case-control study , 2018, Lipids in Health and Disease.

[24]  B. Neale,et al.  Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.

[25]  Y. Liu,et al.  Association of total cholesterol, low‐density lipoprotein cholesterol, and non‐high‐density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population , 2018, International journal of cancer.

[26]  Xiaojing Lin,et al.  Dietary Cholesterol Intake and Risk of Lung Cancer: A Meta-Analysis , 2018, Nutrients.

[27]  Christian Gieger,et al.  Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis , 2017, PLoS Medicine.

[28]  Lei Lu,et al.  Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies. , 2017, Journal of clinical lipidology.

[29]  L. Kiemeney,et al.  Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study , 2017, PloS one.

[30]  William S. Bush,et al.  Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes , 2017, Nature Genetics.

[31]  I. Idris,et al.  Relationship between HbA1c and cancer in people with or without diabetes: a systematic review , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[32]  J. Manson,et al.  Lipid biomarkers and long-term risk of cancer in the Women's Health Study. , 2016, The American journal of clinical nutrition.

[33]  M. Hendryx,et al.  Pre-existing diabetes and lung cancer prognosis , 2016, British Journal of Cancer.

[34]  M. M. Rahman,et al.  Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .

[35]  Stephen Burgess,et al.  Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.

[36]  S. Thompson,et al.  Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects , 2015, American journal of epidemiology.

[37]  A. Tall,et al.  Cholesterol, inflammation and innate immunity , 2015, Nature Reviews Immunology.

[38]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[39]  C. Tseng Diabetes but Not Insulin Increases the Risk of Lung Cancer: A Taiwanese Population-Based Study , 2014, PloS one.

[40]  L. Zelek,et al.  Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk , 2014, European Journal of Epidemiology.

[41]  F. Tinahones,et al.  Inflammation, oxidative stress and metabolic syndrome: dietary modulation. , 2014, Current vascular pharmacology.

[42]  D. Arveiler,et al.  Lipoprotein(a) plasma levels and the risk of cancer: the PRIME study , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[43]  Juhua Luo,et al.  Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients. , 2012, Lung cancer.

[44]  S. Thompson,et al.  Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.

[45]  Anne Tybjærg-Hansen,et al.  Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. , 2011, Journal of the National Cancer Institute.

[46]  P. Stattin,et al.  Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study , 2011, Cancer Causes & Control.

[47]  P. Stattin,et al.  Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts , 2009, PLoS medicine.

[48]  J. Klenk,et al.  Serum triglyceride concentrations and cancer risk in a large cohort study in Austria , 2009, British Journal of Cancer.

[49]  T. Trikalinos,et al.  Statins, low-density lipoprotein cholesterol, and risk of cancer. , 2008, Journal of the American College of Cardiology.

[50]  C. Roberts,et al.  Diabetes and the risk of lung cancer. , 2005, Diabetes care.

[51]  J. Samet,et al.  Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.

[52]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..